Perspective Therapeutics |

Skip to main content

Skip to Investors Navigation

About
Technology
Therapeutic Areas
Pipeline
Newsroom
Investor Center

Careers
Contact

Newsroom

Press Release

View All

Stay up to date

Want to keep up-to-date on news and information?

Email

By subscribing you agree to our Privacy Policy.

About

Company
Management Team
Corporate Governance

Technology

Pb-based α-Particle Therapy
Precision Radiopharmaceuticals
Pb-Specific Chelator (PSC)
Theranostics Platform
Manufacturing/Logistics

Therapeutic Areas

Neuroendocrine Tumors
Melanoma
Solid Tumors

Pipeline

Program Overview
VMT-α-NET
VMT01/02
PSV359
Pre-Targeting Platform
Expanded Access

Newsroom

News
Press Releases
Publications

Investor Center

Overview
Events
SEC Filings
Stock Data
Corporate Governance
Contact Info
Alerts

Privacy Policy
Terms of use

Investor Relations Website By VendorGroup®

This site uses cookies to improve your experience on our site, analyze site traffic and to show you relevant content. By using our website, you consent to our use of cookies. For more information please, see our Privacy Policy.